Healthcare

Healthcare Summary

      % Change
Healthcare+4.22%
Dow +6.54%
Nasdaq +5.18%
S&P 500 +6.32%

Daily Leaders in Healthcare

  Last Change % Change
AMGN54.90+4.77+9.52%
STJ27.64+2.16+8.48%
PFE15.67+1.22+8.44%
MDT30.98+1.94+6.68%
JNJ58.35+3.00+5.42%

Daily Laggards in Healthcare

  Last Change % Change
CELG47.50-3.54-6.94%
DNA72.74-0.29-0.40%
BIIB39.64-0.13-0.33%
BDX61.13+0.87+1.44%
LLY30.43+0.52+1.74%

PFE 15.67 +8.44%

Pfizer who is currently sitting on $25 billion in cash is looking to acquire biotech companies on the cheap. The company has recently done two $200 million acquisitions and is now looking to acquire more companies who might be on the verge of producing the next big vaccine.

220 days 9 hours ago by Tim

GSK 32.85 +0.95%

GlaxoSmithKline has agreed to acquire Reliant Pharmaceuticals for $1.65 billion in cash. The move is expected to increase its drug sales in the U.S. Glaxo has had a rough couple of months after slowing sales of its core diabetes drug Avandia, following a report linking the drug to increased heart-attack risks.

1 year 2 days ago by Tim

LLY 30.43 +1.74%

Eli Lilly and Company India launced an injection treatment named Byetta aimed to improve blood sugar control for patients with type 2 diabeties in India. Byetta is not a replacement for insulin; instead, Byetta is designed to help the body make more of its own insulin. India is now the fourth major market to have Byetta approved, following successful launches in the US, UK, and Germany.

1 year 4 days ago by Tim

BIIB 39.64 -0.33%

Biogen Idec is considering buyout offers after billionaire investor Carl Icahn and other potential buyers have expressed interest in acquiring the company. Biogen is one of the largest biotechnology companies that has been dealing with slowing growth for its primary product, a multiple sclerosis drug, Avonex.

1 year 41 days ago by Tim

DGX 43.08 +5.18%

Robert Hagemann, CFO of Quest Diagnostics, sold 12,502 shares of common stock on Friday.

1 year 114 days ago by Tim

BDX 61.13 +1.44%

Moody's downgraded Boston Scientific to junk status citing poor Q2 performance.

1 year 114 days ago by Tim

STJ 27.64 +8.48%

St. Jude reported Thursday that the U.S. Food and Drug Administration approved their new heart access device for use during cardiac procedures.

1 year 114 days ago by Tim

CELG 47.50 -6.94%

UBS reiterated its buy rating for Celgene with a price target of $75.

1 year 114 days ago by Tim

MDT 30.98 +6.68%

Medtronics purchased Kyphon for $3.9 billion. Kyphon specializes in devices for treating spinal disorders.

1 year 114 days ago by Tim

DNA 72.74 -0.40%

Genentec posted a 41% increase in revenues partly due to a 33% increase in Avastin sales. Avastin fights several forms of lung, breast, and colon cancer.

1 year 114 days ago by Tim

AMGN 54.90 +9.52%

Shares of Amgen dropped for a second day as the Centers for Medicare and Medicaid Services announced more stricter guidelines for medical reimbursements of Amgen's top selling drugs Aranesp and Epogen.

1 year 114 days ago by Tim

MRK 24.40 +3.57%

Judy C. Lewent the CFO of Merck sold 50,000 shares of common stock on Thursday.

1 year 114 days ago by Tim

PFE 15.67 +8.44%

A multinational study sponsored by Pfizer reported positive effects for the treatment of Alzheimer's.

1 year 116 days ago by Tim

JNJ 58.35 +5.42%

Johnson & Johnson announced that they are cutting their workforce at the lititz facility by 300 to 340 positions as its ongoing effort to remain competitive in the marketplace.

1 year 117 days ago by Tim